What is the price target for BFRI stock?
8 analysts have analysed BFRI and the average price target is 6.12 USD. This implies a price increase of 524.55% is expected in the next year compared to the current price of 0.9799.
BIOFRONTERA INC (BFRI) Forecast, Price Target & Analyst Ratings
NASDAQ:BFRI • US09077D2099
Current stock price
0.9799 USD
+0.06 (+6.41%)
At close:
0.96 USD
-0.02 (-2.03%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOFRONTERA INC (BFRI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.12
- Revenue Estimate
- 10.455M
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.12
Upside
+ 524.55%
From current price of $0.98 to mean target of $6.12, Based on 8 analyst forecasts
Low
$3.03
Median
$6.12
High
$9.45
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for BFRI. The average price target is 6.12 USD. This implies a price increase of 524.55% is expected in the next year compared to the current price of 0.9799.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
BFRI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BFRI.
In the previous month the buy percentage consensus was at a similar level.
BFRI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-19 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-15 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-16 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-31 | Benchmark | Reiterate | Buy -> Buy |
| 2023-07-05 | Benchmark | Maintains | Buy -> Buy |
| 2023-05-15 | Benchmark | Reiterate | Buy -> Buy |
| 2023-03-09 | Benchmark | Reiterate | Buy |
| 2023-01-31 | Benchmark | Reiterate | Buy |
| 2021-12-15 | Benchmark | Initiate | Buy |
| 2021-11-24 | Roth Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.12
- Revenue Estimate
- 10.455M
- Revenue Q2Q
- 21.74%
- EPS Q2Q
- 75.04%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
3.92%
EPS (1 Month)
0.00%
EPS (3 Months)
30.00%
Next Earnings Summary
BFRI is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 10.46M USD.
The next earnings revenue estimate has been revised upward by 3.92% in the past 3 months.
Full Analyst Estimates 2026 - 2031
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.071M 18.84% | 37.321M 9.54% | 41.705M 11.75% | 47.693M 14.36% | 55.791M 16.98% | 64.631M 15.84% | 80.154M 24.02% | 97.075M 21.11% | 112.46M 15.85% | |
| EBITDA YoY % growth | -20.871M -21.41% | -16.789M 19.56% | -11.21M 33.23% | -2.856M 74.52% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -21.375M -20.69% | -17.21M 19.49% | -11.348M 34.06% | -1.32M 88.36% | 7.108M 638.33% | 13.538M 90.46% | 22.405M 65.50% | 34.546M 54.19% | 45.335M 31.23% | |
| Operating Margin | -62.74% | -46.11% | -27.21% | -2.77% | 12.74% | 20.95% | 27.95% | 35.59% | 40.31% | |
| EPS YoY % growth | -19.27 -100.73% | -4.16 78.41% | -1.18 71.71% | -0.09 92.63% | 0.14 264.71% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 75.04% | -0.08 85.68% | -0.16 74.50% | 0.32 -34.53% |
| Revenue Q2Q % growth | 10.455M 21.74% | 10.71M 18.60% | 9.69M 38.67% | 16.838M -1.53% |
| EBITDA Q2Q % growth | -102K 97.74% | -2.04M 59.39% | -1.836M 70.40% | 1.224M -73.94% |
| EBIT Q2Q % growth | -1.367M 69.93% | -970.53K 80.89% | -1.882M 70.02% | 3.788M -16.91% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
14.00%
Revenue Next 5 Year
18.49%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOFRONTERA INC / BFRI Forecast FAQ
What is the next earnings date for BFRI stock?
BIOFRONTERA INC (BFRI) will report earnings on 2026-05-13.
What are the consensus estimates for BIOFRONTERA INC (BFRI) next earnings?
The consensus EPS estimate for the next earnings of BIOFRONTERA INC (BFRI) is -0.12 USD and the consensus revenue estimate is 10.46M USD.
How many analysts have analysed BIOFRONTERA INC (BFRI)?
The number of analysts covering BIOFRONTERA INC (BFRI) is 8.